ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2842

Predictors of Good Long-Term Renal Outcomes in Lupus Nephritis

William Fung1, Jiandong Su2 and Zahi Touma3, 1Medicine, University of Toronto, Toronto, ON, Canada, 2Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, 3Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Lupus nephritis, outcomes and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster III: Biomarkers and Nephritis

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:   Lupus nephritis (LN) manifests with proteinuria and/or active urine sediment. Renal composite indices include proteinuria, urinary active sediment (RBCs, casts) and serum creatinine. Complete proteinuria recovery (CR) is defined as <0.5 g/d but it is currently unclear which proteinuria cutoff best predicts good clinical outcomes.

We aimed to determine: a) the predictive ability of proteinuria, urinary sediment (uRBCs) and serum creatinine (Cr) at 1 year to predict good long-term outcomes, and b) the best proteinuria cut-off at 1 year to predict good long-term outcomes.

Methods:  This retrospective analysis was performed on prospective data from a single lupus cohort of 1849 patients. Patients with LN (24-hr proteinuria [24H-P] >0.5 g/d) were identified and baseline was defined as the onset of LN. Patients on whom microscopic urine analysis with at least 7 years’ follow-up were studied. Patients with end-stage renal disease (ESRD) or renal transplant/dialysis at baseline were excluded.  Good renal outcome was defined as Cr <100 mmol/L and renal transplant/dialysis-free at 7 years.

Receiver operating characteristic (ROC) curves were generated to examine the predictive power of Cr, 24H-P, and uRBCs at 1 year post-LN diagnosis with respect to good renal outcome. Area under curves (AUC) were analyzed for: a) 24H-P at year 1, b) absolute change in 24H-P between year 1 and 7, and c) percent change in 24H-P between year 1 and 7. The proteinuria cutoff was identified by optimizing sensitivity and specificity. Additional sensitivity analyses were conducted for patients with baseline 24H-P of >2.5 g/d, >2.0 g/d, and >1.5 g/d. This analysis was repeated for uRBCs and Cr.

Results:  101 LN patients were analyzed, with baseline 24H-P of 2.36 ± 2.31 g/d. At 7 years Cr was 85.6 ± 40.0 mmol/L. 24H-P of 0.6 g/d at 1 year after LN diagnosis best predicted good long-term renal outcome, with sensitivity 62% and specificity 70% (Fig. 1). In the sensitivity analyses, proteinuria cut-off of 1.0 g/d was identified for groups with baseline 24H-P >2.5 g/d, >2.0 g/d, and >1.5 g/d.  

The AUC analysis confirmed that 24H-P at 1 year, but not absolute/percent change, is a predictor of good long-term renal outcomes (Fig. 1, 2). uRBCs did not provide any predictive benefit while Cr at 1 year predicted long-term renal outcome with an AUC of 0.82 (Fig. 2).  

Conclusion:   Proteinuria of 0.6 g/d at 1 year post-LN diagnosis best predicted good long-term renal outcome. Serum creatinine at 1 year was also a strong predictor of long-term renal outcome, whereas urinary RBCs did not offer any prognostic benefit.

 

 

 

Figure 1. ROC curve for proteinuria at 1 year, absolute change and percentage of change between year 1 and 7

 

 

 

 

Figure 2. ROC analyses for proteinuria levels, Cr and uRBC at 1 year, absolute change and percentage of change between at year 1 and 7

 


Disclosure: W. Fung, None; J. Su, None; Z. Touma, None.

To cite this abstract in AMA style:

Fung W, Su J, Touma Z. Predictors of Good Long-Term Renal Outcomes in Lupus Nephritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/predictors-of-good-long-term-renal-outcomes-in-lupus-nephritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictors-of-good-long-term-renal-outcomes-in-lupus-nephritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology